Clinical Use of Cangrelor After Percutaneous Coronary Intervention in Patients Requiring Mechanical Circulatory Support.
Alyson KatzTyler C LewisSerena ArnoukDiana AltshulerJohn PapadopoulosBridget ToyDeane E SmithCristian MerchanPublished in: The Annals of pharmacotherapy (2021)
This case series suggests that cangrelor doses less than 0.75 µg/kg/min may be beneficial. Larger studies should evaluate alternative dosing regimens.
Keyphrases
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- newly diagnosed
- acute coronary syndrome
- coronary artery disease
- prognostic factors
- acute myocardial infarction
- peritoneal dialysis
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- atrial fibrillation
- patient reported outcomes
- coronary artery bypass grafting
- left ventricular